news
FDA announces changes that will soon affect compounders
A change to the law will soon be impacting compounding of certain products beginning on 23 March 2020 the US Food and Drug Administration (FDA) has announced.
List view / Grid view
Contract Manufacturing
article
Trends in the CDMO industry for 2020
Over the past decade, the pharmaceutical industry has witnessed rapid growth in outsourcing services, driven by various factors including the growth of small molecules, increasing API complexities and the need to optimise costs. Here, Peter DeYoung shares his thoughts on the key trends he expects to see in the contract…
article
Using plants as bioreactors to produce proteins for therapeutics
European Pharmaceutical Review explores how plants can be used for large-scale, glycosylated protein bioproduction for the pharma industry.
news
New report shows strong performance in the dose CMO industry
The dose CMO industry is performing strongly despite challenges of increasingly complex drug production, says a new report.
article
Regulatory non-compliance business interruptions
Loss of manufacturing capability as a result of regulatory non-compliance can have a devastating impact on biopharma or medical device manufacturers. In this article, Jenny Yu shares real-life examples from the industry and highlights the downstream effects of these business interruptions.
news
Demand for containment facilities and manufacturing to grow
The market for containment facilities and containment manufacturing will increase in the future, due to a growing demand for oncology treatments.
news
Biotechpharma to expand process development and GMP manufacturing capacity to 5,000 L
Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors
news
Ensuring supplier and compounded drug quality
It is paramount that manufacturers and their suppliers ensure that the quality of compounded drugs are high, by preventing risks of contamination...
product
Meet Danilo Neri, PQE Group Vice President
Find out more about PQE Group services from our Vice President and Partner Danilo Neri at last PharmaLab 2018 in Dusseldorf.
whitepaper
Whitepaper: Ten things you should know before contracting a custom synthesis project
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
news
Top current pharmaceutical outsourcing trends
Most pharmaceutical companies are now outsourcing work to smaller firms, and here, European Pharmaceutical Review looks at current trends...
news
Pharmaceutical outsourcing market forecast 2017-2025
A market report has given a complete backdrop analysis of the pharmaceutical outsourcing market, including market growth and shares...
news
Boosting the safety of bulk drug substances is aim of FDA measures
Boosting the safety of compounded drugs is the aim of new plan from the US Food and Drug Administration (FDA), which has unveiled a series of measures.
news
ProCellicssup™ in-line and real-time bioprocess raman analyser multi-channel unit
ProCellics™, first in-line and real-time bioprocess raman analyser, is a RESOLUTION Spectra Systems product. It offers a GMP user-friendly and easily deployed Process Analytical Technology (PAT) solution...
article
Manufacturing In-Depth Focus 2018
This issue recaps the Joint Pharmaceutical Analysis Group's symposium on Continuous Manufacturing, and explores the "perfect technology storm" facing the pharmaceutical sector.
